According to Xenetic Biosciences's latest financial reports the company has $8.98 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $13.09 M | -28.21% |
2021-12-31 | $18.24 M | 58.26% |
2020-12-31 | $11.52 M | 11.18% |
2019-12-31 | $10.36 M | 1713.83% |
2018-12-31 | $0.57 M | -89.67% |
2017-12-31 | $5.53 M | 36.68% |
2016-12-31 | $4.04 M | 2961.45% |
2015-12-31 | $0.13 M | -94.73% |
2014-12-31 | $2.5 M | -48.19% |
2013-12-31 | $4.83 M | -56.55% |
2013-08-31 | $0.05 M | 66.29% |
2012-12-31 | $11.13 M | |
2012-08-31 | $0.03 M | 220.05% |
2011-08-31 | $0.01 M |